In January 2017, experts from all over the world will gather in Berlin for the 1st DZHK Conference on Translational Medicine. They are united by their common goal of having their research findings arrive at patient level. The conference is organised by the German Centre for Cardiovascular Research (DZHK). “But that does not mean that we have only invited cardiologists”, says Prof. Thomas Eschenhagen, spokesperson of the Executive Board. Instead, renowned scientists from various areas of medical research will be present.
Translation means that research findings are swiftly transferred into clinical practice. Questions and problems in this area are similar in all medical specialties. Thus, in the opening lectures representatives from politics, science, industry and regulatory authorities will have the chance to speak. This emphasizes that everyone has to cooperate in the complex and often lengthy translation process from an early stage.
“Outstanding science takes centre stage at the conference. It provides the basis for successful translation”, says Eschenhagen, who is a pharmacologist himself. The spectrum of lecturers ranges from representatives from basic research, via molecular therapies to clinical and epidemiological studies. This means that for example the first successful approaches to gene therapy in dermatoses and myopathies will be presented, but xenotransplantation and the polypill will also be covered.
“We can all still learn a lot from experts from other medical specialties, that is why I am especially excited that we could arrange such a varied programme”, says Eschenhagen. For him, the event would be a success if the participants found the majority of topics surprising and heard them for the first time.
The conference will be conducted in English.
1st DZHK Conference on Translational Medicine
January 11-12, 2017, Berlin, Langenbeck-Virchow-Haus
Christine Vollgraf, Public Relations, German Centre for Cardiovascular Research (DZHK),
Phone: +49 (0) 30 3465 52902, christine.vollgraf(at)dzhk.de